|Is facial wasting so common?
Nov 6, 2003
Hello Dr Young.
I see a lot of postings these days on facial wasting. Even Dr Bob said he's had it. Is it really so common? I am a 29 yr old black female who started therapy some weeks ago with a CD4 of 260 and viral load 13,000. As I am on Zerit (which seems to be the main drug culprit for wasting), nevirapine and lamivudine, what are my chances of developing this wasting?
My doctor says I have nothing to worry about when I suggested being taken off zerit.
Thanks a lot for your response.
| Response from Dr. Young
Thanks for your note.
Facial lipoatrophy is pretty common, particularly among persons receiving d4T. In the ongoing Gilead 903 study, 4% of persons who received d4T with 3TC/Sustiva developed lipoatrophy at 1 year, 12% at 2 years.
I've not started too many persons on d4T initial therapy in recent years because of this and other concerns, and I guess support your question to your doctor. (Indeed, d4T is not on the current British guidelines).
So, keep discussing how you feel and think with your doctor and let us know how things turn out.
Good luck, thanks for reading. BY
Get Email Notifications When This Forum Updates or Subscribe With RSS
- Common Facial Wasting Symptoms
- Common Wasting Symptoms
- Common Wasting Syndrome Symptoms
- Itchy Balls After Receptive Anal Sex Without Condom What Are The Chances Of HIV
- Muscle Ache After Inverted Condom Sign Of HIV AIDS
- Red Spots After Unprotected Sex Without Ejaculation Worried I Have HIV
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.